Treatment for triple-negative breast cancer (TNBC) has changed dramatically in recent years. One of the biggest advances has been the addition of immunotherapy in both earlier-stage and metastatic TNBC. Drugs called immune checkpoint inhibitors, including pembrolizumab (Keytruda), help the immune system recognize and attack cancer cells more effectively. For many patients, these treatments have improved […]